Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2014
04/23/2014CN103739593A Perylene monoimide dimers and preparation method thereof
04/23/2014CN103739592A Method for producing esomeprazole sodium
04/23/2014CN103739591A 7-(3-acylamino-4-oxyiminomethyl-1-piperidyl) fluoroquinolone carboxylic acid and preparation method thereof
04/23/2014CN103739590A Novel pyrazole-4-formic acid ether and synthetic method
04/23/2014CN103739550A 2, 3-dimethyl-6-urea-2H-indazole compound and preparation method and application thereof
04/23/2014CN103734137A Piperazin derivatives and their use in controlling pests
04/23/2014CN103012369B Lansoprazole N crystal form and preparation method and application thereof
04/23/2014CN102958926B Antihistaminic agent
04/23/2014CN102356068B 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
04/23/2014CN102143956B Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
04/23/2014CN102083814B Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
04/23/2014CN101952280B Bicyclic heterocyclic derivative
04/23/2014CN101932571B Compounds having CRTH2 antagonist activity
04/23/2014CN101910131B Carboxamide, sulfonamide and amine compounds and usagmethod thereof
04/23/2014CN101511819B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
04/22/2014US8703948 Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
04/22/2014US8703938 Hepatitis C virus inhibitors
04/22/2014US8703803 Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
04/22/2014US8703801 Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications
04/22/2014US8703787 Methods of using ALK inhibitors
04/22/2014US8703782 Substituted indole derivatives
04/22/2014US8703775 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
04/22/2014US8703774 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
04/22/2014US8703773 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/22/2014US8703772 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/22/2014US8703770 Pyridazine carboxamide orexin receptor antagonists
04/22/2014US8703761 Organic compounds
04/22/2014US8703758 Bicyclic compound
04/22/2014US8703721 Arylalkylamine compound and process for preparing the same
04/22/2014CA2764021C Gpr 119 modulators
04/22/2014CA2659696C 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
04/22/2014CA2637771C Anthranilamide/2-amino-heteroarene carboxamide derivatives
04/22/2014CA2623360C Squaric acid derivatives as inhibitors of histone deacetylase
04/22/2014CA2611295C Isoquinoline derivatives as inhibitors of rho-kinase
04/22/2014CA2589192C Phenyl-piperazin methanone derivatives
04/17/2014WO2014059422A1 Novel process for making compounds for use in the treatment of cancer
04/17/2014WO2014059232A2 Substituted spiropiperidinyl compounds useful as gpr120 agonists
04/17/2014WO2014059214A1 Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/17/2014WO2014059203A1 Crystalline forms of a factor xia inhibitor
04/17/2014WO2014059202A1 Guanidine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/17/2014WO2014058921A2 Substituted pyrimidinyl kinase inhibitors
04/17/2014WO2014058747A1 5-phenoxy-3h-pyrimidin-4-one derivatives and their use as hiv reverse transcriptase inhibitors
04/17/2014WO2014058183A1 Compound for organic electronic device, organic electronic device using same, and electronic apparatus of said organic electronic device
04/17/2014WO2014057874A1 Fluoranthene derivative, luminescent element material containing same, and luminescent element
04/17/2014WO2014057772A1 Novel pyrazole derivative
04/17/2014WO2014057435A1 Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives
04/17/2014WO2014057291A1 Compounds and their synthesis
04/17/2014WO2014057080A2 Cyclic amines
04/17/2014WO2014057078A1 Benzamides
04/17/2014WO2014056938A1 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
04/17/2014WO2014056771A1 New pyrrolidine derivatives and their use as acetyl-coa carboxylase inhibitors
04/17/2014WO2014056396A1 Flumatinib mesylate crystal form and preparation method and use thereof
04/17/2014WO2014056083A1 Kinase inhibitors and method of treating cancer with same
04/17/2014WO2013064461A3 Compounds with nematicidal activity
04/17/2014US20140107340 Benzamides
04/17/2014US20140107335 Cyclic Amines
04/17/2014US20140107327 Methods for preparing deuterated 1,2,3-triazoles
04/17/2014US20140107164 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
04/17/2014US20140107158 Methods for treating cognitive disorders
04/17/2014US20140107157 Pyrazole derivatives as cannabinoid receptor 1 antagonists
04/17/2014US20140107155 Substituted heterocyclic compounds as ion channel modulators
04/17/2014US20140107151 Tyrosine kinase inhibitors
04/17/2014US20140107143 Quaternary opioid carboxamides
04/17/2014US20140107131 Pyrazolylaminopyridines as inhibitors of fak
04/17/2014US20140107125 Hydrazonopyrazole derivatives and their use as therapeutics
04/17/2014US20140107120 Dual-acting benzoimidazole antihypertensive agents
04/17/2014US20140107111 Use of sigma ligands in diabetes type-2 associated pain
04/17/2014US20140107110 Anti-fibrotic pyridinones
04/17/2014US20140107106 Therapeutic agents, and methods of making and using the same
04/17/2014US20140107097 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
04/17/2014US20140107096 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
04/17/2014US20140107094 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt
04/17/2014US20140107073 GDF-8 Inhibitors
04/16/2014EP2719693A1 Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound
04/16/2014EP2719688A1 Process for producing tetrazolyloxime derivatives
04/16/2014EP2719687A1 Process to make a bromopicoline derivative
04/16/2014EP2719686A1 Process to halogenate a picoline derivative
04/16/2014EP2718288A1 Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
04/16/2014EP2718285A1 Hydantoin derivates as kv3 inhibitors
04/16/2014EP2718284A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
04/16/2014EP2718283A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
04/16/2014EP2718282A1 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
04/16/2014EP2718281A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
04/16/2014EP2718280A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
04/16/2014EP2718279A1 Novel compounds as modulators of gpr-119
04/16/2014EP2718271A1 Substituted benzamide derivatives
04/16/2014EP2718270A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
04/16/2014EP2718267A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
04/16/2014EP2718266A1 Pyridin- 2 -amides useful as cb2 agonists
04/16/2014EP2717694A1 Novel compounds
04/16/2014CN103732612A NOTCH pathway signaling inhibitor compound
04/16/2014CN103732588A Spirocyclic molecules as protein kinase inhibitors
04/16/2014CN103732577A New thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments
04/16/2014CN103732229A Method for treating cancer by combined use of medicinal agents
04/16/2014CN103732067A Compounds,compositions and therapeutic uses thereof
04/16/2014CN103728294A Applications of bisbenzimidazole bicarbazole compound in specific binding nucleic acid G-quadruplex structure and anti-tumor drug
04/16/2014CN103724351A Compound for treating cerebral palsy and use thereof
04/16/2014CN103724330A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
04/16/2014CN103724329A Preparation method of 4-[5-(pyridyl-4-yl)-1H-[1,2,4]triazolyl-3-yl]pyridyl-2-formonitrile
04/16/2014CN103724328A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 1080